Hypothalamic resistin induces hepatic insulin resistance

Evan D. Muse, Tony K T Lam, Philipp E. Scherer, Luciano Rossetti

Research output: Contribution to journalArticle

93 Scopus citations

Abstract

Circulating resistin stimulates endogenous glucose production (GP). Here, we report that bi-directional changes in hypothalamic resistin action have dramatic effects on GP and proinflammatory cytokine expression in the liver. The infusion of either resistin or an active cysteine mutant in the third cerebral ventricle (icv) or in the mediobasal hypothalamus stimulated GP independent of changes in circulating levels of glucoregulatory hormones. Conversely, central antagonism of resistin action markedly diminished the ability of circulating resistin to enhance GP. We also report that centrally mediated mechanisms partially control resistin-induced expression of TNF-α, IL-6, and SOCS-3 in the liver. These results unveil what we believe to be a novel site of action of resistin on GP and inflammation and suggest that hypothalamic resistin action can contribute to hyperglycemia in type 2 diabetes mellitus.

Original languageEnglish (US)
Pages (from-to)1670-1678
Number of pages9
JournalJournal of Clinical Investigation
Volume117
Issue number6
DOIs
StatePublished - Jun 1 2007

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Hypothalamic resistin induces hepatic insulin resistance'. Together they form a unique fingerprint.

  • Cite this